The synthetic biology market comprises a network of players involved in the research and product development; raw material supply; component manufacturing; distribution and sale; and post-sales services.
Key players considered in the analysis of the global market are Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), Amyris (US), GenScript (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US).The global synthetic biology market is expected to grow from USD 3.57 billion in 2017 to USD 8.84 billion by 2022, at a CAGR of 19.9% from 2017 to 2022.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889Synthetic biology has an array of applications in the fields of medicine, agriculture, nanotechnology, and industrial biotechnology.
This has attracted interests of researchers from across the globe and has led to a rise in funding from public and private organizations, which, in turn, help in the growth of the market.Additionally, the reduction in costs per raw megabase of DNA sequencing and a drastic reduction in the cost of synthetic genes is expected to propel the market growth of synthetic biology.
The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.Global Synthetic Biology Market Segmentation:In this report, the market is segmented by tool, technology, application, and region.
On the basis tool, the synthetic biology market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids.
The chassis organisms segment is expected to grow at the highest rate during the forecast period.